Frank Mullery
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Frank Mullery
Frank Mullery is recorded as CEO at Harrow, Inc. (HROW). Harrow, Inc. reported in an 8-K filed October 6, 2025 that Frank Mullery was appointed Chief Executive Officer of ImprimisRx, effective October 6, 2025.
“Frank Mullery has been appointed as Chief Executive Officer and Bridseida Cruz has been appointed as Head of Quality of ImprimisRx.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-10-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harrow, Inc.
Other people whose current roles at this company are on record from its filings.
- Francis W. Mullery CEO
- John P. Saharek CEO
- Mark L. Baum CEO
- Robert J. Kammer Chairman
- Andrew Boll CFO
- Andrew R. Boll CFO
- Randall E. Pollard Chief Accounting Officer
- Adrienne L. Graves Board Member
- Adrienne L. Graves, Ph.D. Board Member
- Lauren P. Silvernail Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.